Altratech
The company develops a multi-analyte molecular detection platform capable of simultaneously quantifying DNA, RNA, antibodies, and antigens. This system combines concurrent serology and nucleic acid detection for use in point-of-care molecular diagnostics. Their technology is applied to clinical needs such as HIV viral load testing in low-income regions and SARS-CoV-2 detection using saliva samples.
Visit websiteCork, Ireland
Healthtech
Biotechnology
Diagnostics
Medical Devices
Funding summary
- Total raised
- €6.5M
- Funding rounds
- 2
Investors in Altratech
Investors on record for Altratech. Click any investor to view their CAPLINK profile and funding criteria.
Fundraising for a startup like Altratech?
Explore CAPLINK's investor database of thousands of active VCs and angels.
Browse investors